Immuno, targeted therapy provide new options for difficult-to-treat head and neck cancer

Novel strategies are on the way for difficult-to-treat and advanced head and neck cancer, the most heterogeneous group of malignancies which are generally associated with poor survival, say researchers.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1TSt3Q2